Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)
Status:
Recruiting
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
This research study is studying a drug as a possible treatment for Angiosarcoma or
Epithelioid hemangioendothelioma (EHE).
-The drug involved in this study is Eribulin